# Phase I Clinical Trial of DA-6886 in Healthy Male Subjects

> **NCT01633723** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 105 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** DA-6886
- **DRUG:** Placebo of DA-6886

## Key facts

- **NCT ID:** NCT01633723
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2021-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01633723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01633723, "Phase I Clinical Trial of DA-6886 in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01633723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*